Phenomenex Announces Acquisition of two Companies in Italy and Denmark
News Apr 13, 2007
Phenomenex, Inc. has announced that it has acquired Bologna-based Chemtek Analytica S.R.L., a subsidiary of Labservice Analytica S.R.L., and privately-held SupWare, headquartered in Hilleroed, Denmark.
Both companies were exclusive distributors for chromatography products developed by Phenomenex. Terms of the acquisitions were not disclosed.
“Phenomenex has had long, successful partnerships with these companies, so buying them represents a natural progression for us,” says Fasha Mahjoor, founder and chief executive officer of Phenomenex.
“They understand our focus on constant innovation and unyielding drive to maintain our position as the technology leader in chromatography. Both share with us a commitment to stay close to the customer. As members of the growing Phenomenex family, they will play an indispensable role in building a cohesive, unifying, worldwide brand presence,” Mahjoor continued.
Plans call for both companies to assume the Phenomenex corporate identity. In Italy, the company will be called
Phenomenex S.R.L. In Denmark, the company will be known as Phenomenex ApS.
“Chemtek has collaborated closely with Phenomenex for more than 20 years,” says Alberto Albieri, newly-appointed sales and marketing manager with Phenomenex – Italy and one of the founders and directors of Chemtek Analytica.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.